Skip to content

Real-world research and promotion of perioperative electrophysiological precision therapy

Real-world research and promotion of perioperative electrophysiological precision therapy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100051103
Enrollment
Unknown
Registered
2021-09-13
Start date
2021-12-01
Completion date
Unknown
Last updated
2022-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention Group:Low frequency neuromuscular stimulator therapy

Sponsors

Shengjing Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with gynecology, general surgery and urology pelvic and abdominal surgery diseases who are admitted to 100 or more medical centers nationwide and require surgical treatment; 2. Aged 18-80 years; 3. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with major medical diseases who cannot tolerate surgery; 2. Patients with major surgical history, patients with severe scar constitution, patients with severe diabetes, uncontrolled hypertension, and patients with other diseases that seriously affect the rapid recovery after surgery; 3. The treatment site is damaged, ulcerated or infected; coma, acute infection, pregnancy, menstruation, uterine bleeding; high fever, heart, liver and kidney insufficiency; 4. On or near medical stimulators, monitors or their leads such as cardiac stents and pacemakers; 5. Patients with a history of lower extremity deep vein thrombosis, patients with malignant tumors and patients with other chronic diseases; 6. Patients with contraindications to electrical stimulation therapy, who are hesitant or uncooperative; patients who cannot be followed up as required; 7. Serious adverse events occurred during the operation; 8. Patients who are unwilling to continue participating in this trial; 9. Patients for whom the investigator considers it necessary to discontinue the trial.

Design outcomes

Primary

MeasureTime frame
VAS score;Chronic headache incidence;

Countries

China

Contacts

Public ContactWang Min

Shengjing Hospital of China Medical University

wm21st@126.com+86 18940251222

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026